InflaRx NV buy Lifesci Capital
Start price
05.04.23
/
50%
€5.34
Target price
05.04.24
-
Performance (%)
-73.58%
End price
06.04.24
€1.41
Summary
This prediction ended on 06.04.24 with a price of €1.41. The BUY prediction by Lifesci_Capital for InflaRx NV performed very badly with a performance of -73.58%. Lifesci_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| InflaRx NV | 7.542% | 7.542% | 140.877% | -44.405% |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % | 65,21 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % | 90,33 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % | 80,62 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % | 70,74 % |
Comments by Lifesci_Capital for this prediction
In the thread InflaRx NV diskutieren
InflaRx (NASDAQ: IFRX) was upgraded by analysts at Lifesci Capital from a "market perform" rating to an "outperform" rating.
Ratings data for IFRX provided by MarketBeat
In the thread Trading InflaRx NV
Die von Lifesci_Capital gewählte maximale Laufzeit wurde überschritten

